Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP.

van Leeuwen WM, Lehto M, Karisola P, Lindholm H, Luukkonen R, Sallinen M, Härmä M, Porkka-Heiskanen T, Alenius H. · 2009

Read Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP. by van Leeuwen WM, Lehto M, Karisola P, Lindholm H, Luukkonen R, Sallinen M, Härmä M, Porkka-Heiskanen T, Alenius H. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2643002.txt.

Introduction

van Leeuwen and co-authors tested in 2009 what a week of short nights does to the immune system and the heart. Thirteen healthy young men slept only four hours a night for five nights, mimicking a hard working week. Six other men kept eight hours a night as a comparison group. Two full nights of sleep followed for recovery.

After the short nights, a blood marker of inflammation, CRP, had risen well above its starting level. It kept rising even after the recovery weekend. Levels of immune signals called IL-1, IL-6, and IL-17 also climbed, and some cell counts shifted. Heart rate was higher after recovery too. The authors link this pattern of simmering inflammation to the raised heart disease risk seen in poor sleepers.

Catalog record

CREATORvan Leeuwen WM, Lehto M, Karisola P, Lindholm H, Luukkonen R, Sallinen M, Härmä M, Porkka-Heiskanen T, Alenius H.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE31 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2643002

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Sleep Restriction Increases the Risk of Developing Cardiovascular Diseases by Augmenting Proinflammatory Responses through IL-17 and CRP By Wessel M A van Leeuwen, Maili Lehto, Piia Karisola, Harri Lindholm, Ritva Luukkonen, Mikael Sallinen, Mikko Härmä, Tarja Porkka-Heiskanen, Harri Alenius, Naomi Rogers Published in: PLoS ONE DOI: 10.1371/journal.pone.0004589 ABSTRACT Abstract Background Sleep restriction, leading to deprivation of sleep, is common in modern 24-h societies and is associated with the development of health problems including cardiovascular diseases. Our objective was to investigate the immunological effects of prolonged sleep restriction and subsequent recovery sleep, by simulating a working week and following recovery weekend in a laboratory environment. Methods and Findings After 2 baseline nights of 8 hours time in bed (TIB), 13 healthy young men had only 4 hours TIB per night for 5 nights, followed by 2 recovery nights with 8 hours TIB. 6 control subjects had 8 hours TIB per night throughout the experiment. Heart rate, blood pressure, salivary cortisol and serum C-reactive protein (CRP) were measured after the baseline (BL), sleep restriction (SR) and recovery (REC) period. Peripheral blood mononuclear cells (PBMC) were collected at these time points, counted and stimulated with PHA. Cell proliferation was analyzed by thymidine incorporation and cytokine production by ELISA and RT-PCR. CRP was increased after SR (145% of BL; p<0.05), and continued to increase after REC (231% of BL; p<0.05). Heart rate was increased after REC (108% of BL; p<0.05). The amount of circulating NK-cells decreased (65% of BL; p<0.005) and the amount of B-cells increased (121% of BL; p<0.005) after SR, but these cell numbers recovered almost completely during REC. Proliferation of stimulated PBMC increased after SR (233% of BL; p<0.05), accompanied by increased production of IL-1β (137% of BL; p<0.05), IL-6 (163% of BL; p<0.05) and IL-17 (138% of BL; p<0.05) at mRNA level. After REC, IL-17 was still increased at the protein level (119% of BL; p<0.05). Conclusions 5 nights of sleep restriction increased lymphocyte activation and the production of proinflammatory cytokines including IL-1β IL-6 and IL-17; they remained elevated after 2 nights of recovery sleep, accompanied by increased heart rate and serum CRP, 2 important risk factors for cardiovascular diseases. Therefore, long-term sleep restriction may lead to persistent changes in the immune system and the increased production of IL-17 together with CRP may increase the risk of developing cardiovascular diseases. INTRODUCTION Sleep is generally considered to be a restorative process, having beneficial effects on immune functions. Partial loss of sleep is common among people who experience environmental or psychological stress such as travelling across time zones, having to do shift work, and in those individuals with psychiatric or physical disorders. Sleep restriction is becoming increasingly prevalent, especially among employed middle-aged populations [1], [2]. In modern 24-h societies, increased work demands are a major cause of chronic deficiency of sleep, leading to increased amounts of accidents, diseases, and even increased mortality [3]. It is important to understand the mechanisms by which sleep, immune responses and health are related if we are to find ways to manage patients with sleep disorders and people with chronically restricted sleep. Sufficient sleep is vital for cardiovascular health and reduced sleep duration is specifically associated with increased cardiovascular morbidity [4]–[6]. Many cardiovascular risk factors, including heart rate, blood pressure and serum CRP concentrations, have been shown to increase during both short and prolonged periods of sleep restriction [6]. However, the underlying immunological mechanisms leading to the development of cardiovascular diseases remain to be elucidated. In the present study, we simulated the accumulation of sleep loss during five working days followed by two days of weekend recovery sleep, and measured the changes in immunological parameters at these time points. We hypothesize that, in addition to the previously reported adverse effects on cognitive functioning and metabolism [7], [8], continuous sleep restriction disturbs human immunity which could result in an increased risk of developing cardiovascular diseases. MATERIALS AND METHODS Participants and study design Nineteen healthy men, aged 19–29 (mean [SD] age 23.1 [2.5] years), with a regular sleep-wake schedule and habitual sleep duration of 7–9 h participated in the study. Physical screening included blood tests (triglycerides, cholesterol, creatinine, haemoglobin, haematocrit, MCV, MCH, MCHC, leukocytes, erythrocytes, TSH, ASAT, ALAT) and polysomnography (Table S1). Two weeks prior to the experiment, participants completed sleep diaries, had an adaptation night in the sleep laboratory and wore actigraphs in order to verify adherence to a regular sleep-wake schedule. The pre-study mean (SD) sleep duration was 6.88 (0.58) h in the control group and 7.05 (0.80) h in the experimental group. The study design was approved by the ethics committee of Helsinki University Central Hospital, written informed consent was obtained from participants, and the experiment was conducted at the Brain and Work Research Centre of the Finnish Institute of Occupational Health. The experimental group (n = 13) spent 8 h in bed for the first two nights (BL; from 11 PM to 7 AM), followed by 5 nights where they rested for only 4 h in bed (SR; from 3 AM to 7 AM) and, finally, again 3 nights of 8 h in bed (REC). The control group (n = 6) spent 8 h in bed (11 PM to 7 AM) throughout the entire experiment. Napping during daytime was not allowed and this was monitored by continuous EEG recordings and a continuously present investigator. Meals were standardized, provided at fixed times and finished by all participants throughout the experiment: breakfast at 8 AM (600 kcal), lunch at 12.30 PM (800 kcal), dinner at 6 PM (700 kcal); snacks at 3.30 PM (300 kcal) and 9.30 PM (200 kcal). In addition, participants in the experimental group ate a piece of fruit at 12.15 AM. Participants were not allowed to leave the building, but could stay in a living room where there was a television and a personal computer. Illumination in the sleeping room and in the test room ranged from 150 to 400 lux, and in the living room from 350 to 600 lux. The temperature ranged from 19 to 23°C. High sensitivity C-reactive protein (hs-CRP) and cortisol assays Blood samples were taken from participants at 7.30 AM and analyzed by Medix Laboratories, Espoo, Finland for high sensitivity C-reactive protein (hs-CRP) using immunoturbidimetry. Morning peak values of cortisol were assessed using saliva samples that were collected 10 times a day and their cortisol levels were measured using a commercial kit assay (Salivary Cortisol, LIA, IBL, Hamburg, Germany). The measurement range was 0.43–110 nmol/L with assay repeatability values of 5% (within series) and 8% (between series). Heart rate and blood pressure measurements ECG- based (WinAcq, AbsoluteAliens, Finland) heart rate together with continuous systolic and diastolic blood pressure (Portapres, Finapres Medical Systems, the Netherlands) was measured between 8 AM and 9 AM during a 10 minute period of rest. Peripheral blood mononuclear cells and flow cytometry Peripheral blood mononuclear cells (PBMC) were isolated from heparinized venous blood by density gradient centrifugation as earlier described [9]. Cell distribution of PBMC was then assessed by flow cytometry (FACSCalibur, BD Biosciences, San Jose, CA, USA) using FACSComp software version 4.01 (BD Biosciences) [9]. Briefly, PBMC were incubated with (phycoerythrin-Cy5 (PE-Cy5)-conjugated anti-CD3 or with PE-conjugated anti-CD4, anti-CD56, anti-CD19, or with fluorescein isothiocyanate

Read the complete text